云顶新耀与海森生物签署商业化服务协议及授权许可协议 推动商业化协同与多领域布局
Dec 12, 2025 14:35 HKT |  |
|
雲頂新耀與海森生物簽署商業化服務協議及授權許可協議 推動商業化協同與多領域佈局
Dec 12, 2025 14:35 HKT | |
|
Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten
Dec 12, 2025 14:35 HKT | |
|
康哲藥業（0867）抗急性缺血性卒中創新藥注射用Y-3中國NDA獲受理
Dec 11, 2025 20:01 HKT |  |
|
CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China
Dec 11, 2025 20:00 HKT | |
|
康哲药业（0867）抗急性缺血性卒中创新药注射用Y-3中国NDA获受理
Dec 11, 2025 19:53 HKT | |
|
拨康视云股价飙升逾8成 多重利好催化迎价值重估
Dec 11, 2025 08:20 HKT | |
|
Cloudbreak Pharma Soars 80%+ on Multiple Catalysts, Driving Value Re-Rating
Dec 11, 2025 08:20 HKT | |
|
撥康視雲股價飆升逾8成 多重利好催化迎價值重估
Dec 11, 2025 08:20 HKT | |
|
GEN Announces New Positive Phase 1 Trial Data of the Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases
Dec 02, 2025 13:00 HKT |  |
|
GEN 宣布针对阿尔茨海默病及其他神经退行性疾病的试验性药物 SUL-238 取得新的积极 I 期临床试验数据
Dec 02, 2025 13:00 HKT | |
|
GEN 宣布針對阿茲海默症及其他神經退化性疾病之試驗藥物 SUL-238 取得全新第一期試驗正面數據
Dec 02, 2025 13:00 HKT | |
|
AdipoLABs Opens New Regional Office, Signs Two MoUs With University of Cyberjaya to Advance Healthcare Innovation
Dec 02, 2025 12:22 HKT |  |
|
君聖泰醫藥公佈HTD1801與達格列淨的頭對頭III期臨床研究結果 展現控糖優勢及心血管代謝優效獲益
Dec 02, 2025 10:59 HKT |  |
|
君圣泰医药公布HTD1801与达格列净的头对头III期临床研究结果 展现控糖优势及心血管代谢优效获益
Dec 02, 2025 10:16 HKT | |
|
健倍苗苗公布二零二六财政年度中期业绩
Nov 17, 2025 21:43 HKT |  |
|
健倍苗苗公佈二零二六財政年度中期業績
Nov 17, 2025 21:43 HKT | |
|
JBM Healthcare Announces FY2026 Interim Results
Nov 17, 2025 21:43 HKT | |
|
OBI-902获美国FDA审核通过用于治疗胆管癌的“孤儿药”资格认定
Nov 17, 2025 20:00 HKT |  |
|
OBI-902 獲美國 FDA 審核通過治療膽管癌的「孤兒藥」資格認定
Nov 17, 2025 20:00 HKT | |
|